Avoro Capital Advisors LLC - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 152 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$227,092,200
-35.1%
1,555,000
+2.6%
3.54%
-25.4%
Q2 2023$349,999,881
-13.3%
1,515,151
-9.1%
4.75%
-20.7%
Q1 2023$403,766,505
-16.2%
1,666,666
+0.4%
5.99%
-16.9%
Q4 2022$481,815,000
+383.0%
1,660,000
+8.1%
7.20%
+290.7%
Q3 2022$99,760,000
-9.2%
1,535,0000.0%1.84%
-15.1%
Q2 2022$109,875,000
-21.4%
1,535,000
+7.7%
2.17%
-15.0%
Q1 2022$139,821,000
+15.8%
1,425,0000.0%2.55%
+24.2%
Q4 2021$120,755,000
+6.2%
1,425,0000.0%2.06%
+15.1%
Q3 2021$113,701,000
-18.1%
1,425,0000.0%1.79%
-26.0%
Q2 2021$138,809,000
-16.7%
1,425,0000.0%2.42%
-16.1%
Q1 2021$166,682,000
+22.4%
1,425,000
+16.3%
2.88%
+22.8%
Q4 2020$136,183,000
+28.9%
1,225,000
+37.6%
2.34%
+56.2%
Q3 2020$105,670,000
+166.6%
890,000
+154.3%
1.50%
+91.5%
Q2 2020$39,638,000
+70.1%
350,000
+0.3%
0.78%
-0.3%
Q1 2020$23,299,000
-26.7%
349,0000.0%0.79%
-15.8%
Q4 2019$31,797,000
+2.4%
349,000
-3.1%
0.93%
-27.9%
Q3 2019$31,039,000
-17.7%
360,0000.0%1.30%
-0.7%
Q2 2019$37,732,000
-2.8%
360,000
+16.1%
1.30%
-22.3%
Q1 2019$38,831,000
+53.1%
310,000
+37.8%
1.68%
+10.8%
Q4 2018$25,362,000
-74.4%
225,000
-51.4%
1.52%
-66.7%
Q3 2018$99,142,000
-27.6%
463,000
-5.4%
4.55%
-13.6%
Q2 2018$136,918,000489,5365.27%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$5,047,0003.31%
L1 Capital Pty Ltd 161,163$10,474,0002.05%
Avoro Capital Advisors LLC 1,535,000$99,760,0001.84%
Affinity Asset Advisors, LLC 100,000$6,499,0001.81%
GREAT POINT PARTNERS LLC 95,500$6,207,0001.50%
ARMISTICE CAPITAL, LLC 1,236,000$80,328,0001.39%
Affinity Asset Advisors, LLC 75,000$4,874,0001.36%
MPM BioImpact LLC 44,747$2,908,0000.69%
Baker Brothers Advisors 1,499,213$97,434,0000.64%
Perceptive Advisors 331,023$21,513,0000.62%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders